Aura Biosciences, Inc. Increase (Decrease) in Prepaid Expenses, Other
Aura Biosciences, Inc. (AURA) reported Increase (Decrease) in Prepaid Expenses, Other of -$310.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-11
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $1.42M, a 1071.07% increase year-over-year.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$1.73M.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$2.68M, a 731.29% decline year-over-year.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $1.53M, a 66.02% increase year-over-year.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$4.03M, a 203.25% decline from fiscal 2024.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was $3.90M.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$3.58M, a 210.02% decline from fiscal 2022.
- Aura Biosciences, Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $3.25M, a 9.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$310.00K 10-Q · filed 2026-08-11 | -$2.99M derived: sum of 3 quarters · filed 2026-08-11 | -$1.46M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | -$1.73M 10-Q · filed 2026-05-11 | -$4.41M derived: sum of 2 quarters · filed 2026-05-11 | -$2.88M derived: sum of 3 quarters · filed 2026-05-11 | -$2.75M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.15M derived: sum of 2 quarters · filed 2026-03-30 | -$1.03M derived: sum of 3 quarters · filed 2026-08-11 | -$4.03M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.66M derived: sum of 2 quarters · filed 2026-08-11 | -$1.35M 10-Q · filed 2025-11-13 | -$923.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.88M 10-Q · filed 2026-08-11 | -$2.46M derived: sum of 3 quarters · filed 2026-08-11 | -$1.53M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$3.00M 10-Q · filed 2026-05-11 | -$2.58M derived: sum of 2 quarters · filed 2026-05-11 | -$1.65M derived: sum of 3 quarters · filed 2026-05-11 | -$2.85M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.35M derived: sum of 2 quarters · filed 2026-03-30 | $154.00K derived: sum of 3 quarters · filed 2026-03-30 | $3.90M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $924.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$271.00K derived: sum of 2 quarters · filed 2025-11-13 | $3.48M 10-Q · filed 2025-11-13 | $2.96M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $2.56M 10-Q · filed 2025-08-13 | $2.04M derived: sum of 3 quarters · filed 2025-08-13 | $2.92M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $3.75M 10-Q · filed 2025-05-15 | $3.23M derived: sum of 2 quarters · filed 2025-05-15 | $4.11M derived: sum of 3 quarters · filed 2025-05-15 | $2.46M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $361.00K derived: sum of 2 quarters · filed 2025-03-24 | -$1.29M derived: sum of 3 quarters · filed 2025-03-24 | -$3.58M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $881.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$767.00K derived: sum of 2 quarters · filed 2024-11-12 | -$3.06M 10-Q · filed 2024-11-12 | -$217.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.94M 10-Q · filed 2024-08-08 | -$1.10M derived: sum of 3 quarters · filed 2024-08-08 | -$1.58M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$2.29M 10-Q · filed 2024-05-09 | $550.00K derived: sum of 2 quarters · filed 2024-05-09 | $69.00K derived: sum of 3 quarters · filed 2024-05-09 | -$699.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.36M derived: sum of 2 quarters · filed 2024-03-27 | $1.59M derived: sum of 3 quarters · filed 2024-03-27 | $3.25M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.25M derived: sum of 2 quarters · filed 2023-11-09 | $411.00K 10-Q · filed 2023-11-09 | -$411.00K 10-Q · filed 2022-11-10 | $3.42M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $892.00K 10-Q · filed 2023-08-09 | $3.90M derived: sum of 3 quarters · filed 2023-08-09 | $4.86M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $1.66M 10-Q · filed 2023-05-11 | $4.67M derived: sum of 2 quarters · filed 2023-05-11 | $5.63M derived: sum of 3 quarters · filed 2023-05-11 | $5.25M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.97M derived: sum of 2 quarters · filed 2023-03-15 | $3.59M derived: sum of 3 quarters · filed 2023-03-15 | $3.58M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $962.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $581.00K derived: sum of 2 quarters · filed 2022-11-10 | $566.00K 10-Q · filed 2022-11-10 | $679.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$396.00K 10-Q · filed 2022-08-11 | -$283.00K derived: sum of 3 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$15.00K 10-Q · filed 2022-05-12 | $98.00K derived: sum of 2 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $165.00K 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $52.00K 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |